Documentos relacionados

1. Adverse Drug Event Profile Associated with Anti-dementia Drugs: Analysis of a Spontaneous Reporting Database.
2. Acetylcholinesterase inhibitors for autistic spectrum disorders.
3. Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study.
4. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
5. An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease.
6. Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review.
7. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study.
8. The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis.
9. Characteristics of Pediatric Exposures to Antidementia Drugs Reported to a Poison Control System.
10. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.